Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Sep-24 4:15 PM View:  | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Grant | 17,900 | -- | -- | 11% 159.31K to 177.21K | |
| 18-Sep-24 4:15 PM View: | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 89,762 | -- | -- | (51%) 177.21K to 87.45K | |
| 18-Sep-24 4:15 PM View: | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition (change in control) | 87,450 | -- | -- | (100%) 87.45K to 0 | |
| 08-Jul-24 5:57 PM View: | G1 Therapeutics, Inc. (GTHX) | 05-Jul-24 | Sale | 2,475 | $2.51 | $6,206.56 | (2%) 161.79K to 159.31K | |
| 15-May-24 4:08 PM View: | G1 Therapeutics, Inc. (GTHX) | 13-May-24 | Sale | 8,151 | $4.79 | $39,033.50 | (5%) 169.94K to 161.79K | |
| 13-Feb-24 6:14 PM View: | G1 Therapeutics, Inc. (GTHX) | 12-Feb-24 | Option Exercise | 28,600 | $0.30 | $8,580.00 | 17% 169.94K to 198.54K | |
| 13-Feb-24 6:14 PM View: | G1 Therapeutics, Inc. (GTHX) | 12-Feb-24 | Planned Option Sale | 28,600 | $4.62 | $132,143.00 | (14%) 198.54K to 169.94K | |
| 08-Jan-24 6:03 AM View: | G1 Therapeutics, Inc. (GTHX) | 04-Jan-24 | Sale | 721 | $2.94 | $2,121.40 | (< 1%) 170.66K to 169.94K | |
| 08-Jan-24 6:03 AM View: | G1 Therapeutics, Inc. (GTHX) | 03-Jan-24 | Grant | 37,300 | -- | -- | 27% 136.38K to 173.68K | |
| 08-Jan-24 6:03 AM View: | G1 Therapeutics, Inc. (GTHX) | 03-Jan-24 | Sale | 3,019 | $3.12 | $9,415.96 | (2%) 173.68K to 170.66K | |
| 27-Dec-23 5:37 PM View: | Point Biopharma Global Inc. (RACA) | 26-Dec-23 | Disposition (change in control) | 3,700 | -- | -- | (100%) 3.7K to 0 | |
| 13-Dec-23 4:45 PM View: | G1 Therapeutics, Inc. (GTHX) | 11-Dec-23 | Option Exercise | 33,839 | $0.36 | $12,081.20 | 25% 136.38K to 170.22K | |
| 13-Dec-23 4:45 PM View: | G1 Therapeutics, Inc. (GTHX) | 11-Dec-23 | Planned Option Sale | 33,839 | $3.41 | $115,522.00 | (20%) 170.22K to 136.38K | |
| 07-Jul-23 4:08 PM View: | G1 Therapeutics, Inc. (GTHX) | 05-Jul-23 | Sale (Planned) | 1,361 | $2.45 | $3,339.49 | (< 1%) 137.74K to 136.38K | |
| 12-May-23 4:19 PM View: | G1 Therapeutics, Inc. (GTHX) | 10-May-23 | Grant | 35,000 | -- | -- | 34% 102.74K to 137.74K | |
| 05-Jan-23 10:00 PM View: | G1 Therapeutics, Inc. (GTHX) | 05-Jan-23 | Sale | 729 | $5.41 | $3,942.07 | (< 1%) 103.47K to 102.74K | |
| 05-Jan-23 10:00 PM View: | G1 Therapeutics, Inc. (GTHX) | 04-Jan-23 | Sale | 1,639 | $5.58 | $9,138.41 | (2%) 105.11K to 103.47K | |
| 05-Jan-23 10:00 PM View: | G1 Therapeutics, Inc. (GTHX) | 03-Jan-23 | Grant | 17,900 | -- | -- | 21% 87.21K to 105.11K | |
| 16-Dec-22 4:12 PM View: | G1 Therapeutics, Inc. (GTHX) | 15-Dec-22 | Option Exercise | 14,000 | $0.30 | $4,200.00 | 19% 73.21K to 87.21K | |
| 28-Nov-22 4:01 PM View: | Point Biopharma Global Inc. (RACA) | 28-Nov-22 | Private Purchase | 3,700 | $6.66 | $24,642.00 | 100% 0 to 3.7K | |
| 16-Sep-22 4:31 PM View: | G1 Therapeutics, Inc. (GTHX) | 13-Sep-22 | Option Exercise | 18,000 | $0.39 | $7,020.00 | 25% 73.21K to 91.21K | |
| 16-Sep-22 4:31 PM View: | G1 Therapeutics, Inc. (GTHX) | 13-Sep-22 | Planned Option Sale | 18,000 | $15.71 | $282,746.00 | (20%) 91.21K to 73.21K | |
| 06-Jul-22 4:02 PM View: | G1 Therapeutics, Inc. (GTHX) | 05-Jul-22 | Sale | 648 | $5.17 | $3,351.13 | (< 1%) 73.86K to 73.21K | |
| 02-Feb-22 5:20 PM View: | G1 Therapeutics, Inc. (GTHX) | 01-Feb-22 | Option Exercise | 10,000 | $0.30 | $3,000.00 | 16% 63.85K to 73.86K | |
| 05-Jan-22 8:24 PM View: | G1 Therapeutics, Inc. (GTHX) | 05-Jan-22 | Market Sale | 1,445 | $10.61 | $15,333.60 | (2%) 65.3K to 63.85K | |
| 05-Jan-22 8:24 PM View: | G1 Therapeutics, Inc. (GTHX) | 03-Jan-22 | Grant | 12,000 | -- | -- | 23% 53.3K to 65.3K | |
| 11-May-21 4:23 PM View: | G1 Therapeutics, Inc. (GTHX) | 10-May-21 | Option Exercise | 10,000 | $0.30 | $3,000.00 | 23% 43.3K to 53.3K | |
| 23-Apr-21 4:39 PM View: | G1 Therapeutics, Inc. (GTHX) | 22-Apr-21 | Option Exercise | 15,000 | $0.39 | $5,850.00 | 35% 43.3K to 58.3K | |
| 23-Apr-21 4:39 PM View: | G1 Therapeutics, Inc. (GTHX) | 22-Apr-21 | Market Option Sale (Planned) | 15,000 | $22.07 | $331,100.00 | (26%) 58.3K to 43.3K | |
| 24-Mar-21 4:47 PM View: | G1 Therapeutics, Inc. (GTHX) | 23-Mar-21 | Option Exercise | 15,000 | $0.39 | $5,850.00 | 35% 43.3K to 58.3K | |
| 24-Mar-21 4:47 PM View: | G1 Therapeutics, Inc. (GTHX) | 23-Mar-21 | Market Option Sale (Planned) | 15,000 | $21.94 | $329,060.00 | (26%) 58.3K to 43.3K | |
| 04-Mar-21 5:10 PM View: | G1 Therapeutics, Inc. (GTHX) | 02-Mar-21 | Option Exercise | 15,000 | $1.55 | $23,219.10 | 35% 43.3K to 58.3K | |
| 04-Mar-21 5:10 PM View: | G1 Therapeutics, Inc. (GTHX) | 02-Mar-21 | Market Option Sale (Planned) | 15,000 | $22.95 | $344,192.00 | (26%) 58.3K to 43.3K | |
| 29-Jan-21 4:07 PM View: | G1 Therapeutics, Inc. (GTHX) | 27-Jan-21 | Option Exercise | 3,100 | $0.39 | $1,209.00 | 8% 40.2K to 43.3K | |
| 22-Jan-21 6:47 PM View: | G1 Therapeutics, Inc. (GTHX) | 22-Jan-21 | Option Exercise | 15,000 | $4.17 | $62,550.00 | 37% 40.2K to 55.2K | |
| 22-Jan-21 6:47 PM View: | G1 Therapeutics, Inc. (GTHX) | 22-Jan-21 | Market Option Sale (Planned) | 15,000 | $20.64 | $309,591.00 | (27%) 55.2K to 40.2K | |
| 05-Jan-21 6:14 PM View: | G1 Therapeutics, Inc. (GTHX) | 04-Jan-21 | Grant | 11,000 | -- | -- | 38% 29.2K to 40.2K | |
| 11-Dec-20 4:50 PM View: | G1 Therapeutics, Inc. (GTHX) | 10-Dec-20 | Option Exercise | 9,000 | $4.17 | $37,530.00 | 31% 29.2K to 38.2K | |
| 11-Dec-20 4:50 PM View: | G1 Therapeutics, Inc. (GTHX) | 10-Dec-20 | Market Option Sale (Planned) | 9,000 | $20.06 | $180,550.00 | (24%) 38.2K to 29.2K | (< 1%) |
| 16-Mar-20 7:00 AM View: | G1 Therapeutics, Inc. (GTHX) | 13-Mar-20 | Option Exercise | 2,500 | $0.39 | $975.00 | 9% 26.7K to 29.2K | |
| 24-Jan-20 4:58 PM View: | G1 Therapeutics, Inc. (GTHX) | 23-Jan-20 | Option Exercise | 5,000 | $0.39 | $1,950.00 | 23% 21.7K to 26.7K | |
| 28-Jan-19 9:10 PM View: | G1 Therapeutics, Inc. (GTHX) | 28-Jan-19 | Option Exercise | 7,000 | $0.39 | $2,730.00 | 48% 14.7K to 21.7K | |
| 17-Dec-18 4:27 PM View: | G1 Therapeutics, Inc. (GTHX) | 17-Dec-18 | Option Exercise | 3,776 | $4.17 | $15,745.90 | 26% 14.7K to 18.48K | |
| 17-Dec-18 4:27 PM View: | G1 Therapeutics, Inc. (GTHX) | 17-Dec-18 | Market Option Sale (Planned) | 3,776 | $30.00 | $113,280.00 | (20%) 18.48K to 14.7K | 33% |
| 16-Nov-18 5:17 PM View: | G1 Therapeutics, Inc. (GTHX) | 15-Nov-18 | Option Exercise | 3,776 | $4.17 | $15,745.90 | 26% 14.7K to 18.48K | |
| 16-Nov-18 5:17 PM View: | G1 Therapeutics, Inc. (GTHX) | 15-Nov-18 | Market Option Sale (Planned) | 3,776 | $39.75 | $150,105.00 | (20%) 18.48K to 14.7K | 49% |
| 15-Oct-18 5:57 PM View: | G1 Therapeutics, Inc. (GTHX) | 15-Oct-18 | Option Exercise | 6,300 | $0.39 | $2,457.00 | 75% 8.4K to 14.7K | |
| 15-Oct-18 5:57 PM View: | G1 Therapeutics, Inc. (GTHX) | 15-Oct-18 | Option Exercise | 3,776 | $4.17 | $15,745.90 | 26% 14.7K to 18.48K | |
| 15-Oct-18 5:57 PM View: | G1 Therapeutics, Inc. (GTHX) | 15-Oct-18 | Market Option Sale (Planned) | 3,776 | $41.71 | $157,497.00 | (20%) 18.48K to 14.7K | 52% |
| 19-Sep-18 7:07 PM View: | G1 Therapeutics, Inc. (GTHX) | 17-Sep-18 | Option Exercise | 3,776 | $4.17 | $15,745.90 | 45% 8.4K to 12.18K |